Radiation therapy: An old dog learning new tricks
- PMID: 37039770
- DOI: 10.1016/S0091-679X(23)00036-5
Radiation therapy: An old dog learning new tricks
Keywords: Chemotherapy; DNA damage; Immunogenic cell death; Immunotherapy; Radiation therapy; Targeted anticancer agents.
Conflict of interest statement
Conflict of interest LG is/has been holding research contracts with Lytix Biopharma and Promontory, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. All other authors have no conflicts to declare.
LinkOut - more resources
Full Text Sources
